Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 5 The comparison of the treatments between the children with TB using and not using biological agents

From: Tuberculosis in children and adolescents using biological agents: a nationwide cohort study from Turkey

 

Children with TB not using biological agents

n = 4268 (%)

Children with TB using biological agents

n = 83 (%)

P

Steroid

708 (16.6)

76 (91.5)

0.001

Naproxen

462 (10.8)

30 (36.1)

0.001

Diclofenac

675 (15.8)

19 (22.1)

0.094

Colchisin

63 (1.5)

17 (20.5)

0.001

Azathioprine

19 (0.4)

16 (19.3)

0.001

Mesalazin

16 (0.4)

14 (16.9)

0.001

Sulfasalazine

6 (0.1)

10 (12)

0.001

Cyclosporin

47 (1.1)

5 (6)

0.003

Methotrexate

0 (0)

1 (1.2)

-